Pharmanovia Acquires Global Central Nervous System CNS Portfolio From Sanofi
Pharmanovia a global pharmaceutical company that commercialises novel medicines and revitalises extends and expands the lifecycle of established medicines has today announced the expansion of its neurology portfolio with the acquisition of 11 central nervous system CNS brands from global healthcare company Sanofi.
Source: businesswireindia.com